BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6343505)

  • 21. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
    Wasserman RL; Budens RD; Thaxton ES
    J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation.
    Masuho Y; Sugano T; Matsumoto Y; Sawada S; Tomibe K
    Biochem Biophys Res Commun; 1986 Mar; 135(2):495-500. PubMed ID: 3008724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of three methods for production of human hybridomas secreting autoantibodies.
    Niedbala WG; Stott DI
    Hybridoma; 1998 Jun; 17(3):299-304. PubMed ID: 9708833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of an ovine monoclonal antibody to testosterone by an interspecies fusion.
    Groves DJ; Morris BA; Tan K; De Silva M; Clayton J
    Hybridoma; 1987 Feb; 6(1):71-6. PubMed ID: 3679254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
    Foung SK; Engleman EG; Grumet FC
    Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved fusion technique. II. Stability and purity of hybrid clones.
    Westerwoudt RJ; Naipal AM; Harrisson CM
    J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
    Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
    Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of polyethylene glycols as fusogens for producing lymphocyte-myeloma hybrids.
    Lane RD; Crissman RS; Lachman MF
    J Immunol Methods; 1984 Aug; 72(1):71-6. PubMed ID: 6747307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
    Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
    Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An improved in vitro immunization procedure for the production of monoclonal antibodies.
    Boss BD
    Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
    [No Abstract]   [Full Text] [Related]  

  • 38. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
    Holzlöhner P; Hanack K
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion.
    Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U
    J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
    Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
    Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.